Tau binding compounds
US12291565B2 · kind B2 · utility
0Cited by
33References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2024 |
| Grant date | May 6, 2025 |
| Priority date | — |
| Expiry date | Jun 5, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides anti-tau antibodies and vectorization thereof (e.g., into AAV particles). Also provided are methods of using anti-tau antibodies and/or AAV particles for prevention, treatment, and/or diagnosis of neurological indications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.